NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Thursday, May 29, 2008  
As Population (Online Pharmacy) Ages And Need For Palliative Care Grows, Experts Tackle New Challenge For The First Time At European Meeting
As Population Ages And Need For Palliative Care Grows, Experts Tackle New Challenge For The First Time At European Meeting
Experts from across Europe are gathering at a scientific symposium held at the fifth European Association for Palliative Care (EAPC) congress in Trondheim, Norway, on the 29th May, to discuss the challenges of managing an overlooked and distressing symptom that affects large numbers of patients receiving opioids as part of palliative care management for advanced illness: opioid-induced constipation (OIC).
Source: www.medicalnewstoday.com

AVANIR Announces Positive Outcome Of Zenvia PK Study
AVANIR Pharmaceuticals (NASDAQ:AVNR) reported a positive outcome of its large, formal pharmacokinetic (PK) study of its investigational drug Zenvia? (dextromethorphan/quinidine [DM/Q]). The objective of the formal PK study was to support identification of an alternative dosing formulation of Zenvia designed to deliver similar efficacy as observed in the first Phase III clinical study in diabetic peripheral neuropathic (DPN) pain but with an improved safety and tolerability profile.
Source: www.medicalnewstoday.com

New England Journal Of Medicine Publishes Results From A RELISTOR Phase 3 Clinical Study
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced the publication of results from a pivotal phase 3 trial of RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection in the May 29, 2008 issue of the New England Journal of Medicine.
Source: www.medicalnewstoday.com

Most Developing Countries Ill-Equipped To Ensure Global Biosafety: UN University
A two-year UN study of internationally funded training programmes in biotechnology and biosafety warns that as many as 100 developing countries are unprepared to effectively manage and monitor the use of modern biotechnologies, leaving the world community open to serious biosafety threats.
Source: www.medicalnewstoday.com

Analytical Technology's New Gassens Monitor Enables Safe And Efficient Gas Detection In The Pharmaceutical Industry
Specialist electrochemical sensor manufacturer, Analytical Technology Inc. announces that its GasSens monitor enables safe and efficient continuous on-line monitoring and control of gas detection in the pharmaceutical industry. Analytical Technology is the de facto company for chlorine monitoring in water, and the recent introduction of the GasSens monitor to the UK market complements the company's existing portfolio of water and gas instrumentation.
Source: www.medicalnewstoday.com

Australian Full Federal Court Upholds Basic Lipitor Patent, Preventing Launch Of Generic Ranbaxy Product
Pfizer Inc said that the Australian Full Federal Court in Victoria has upheld on appeal the exclusivity of its basic patent covering atorvastatin, the active ingredient in Lipitor. The ruling, the culmination of a lawsuit filed in 2005 by generic drug manufacturer Ranbaxy, preserves Lipitor's patent coverage in Australia through May 2012. Ranbaxy can appeal the decision.
Source: www.medicalnewstoday.com

New Book Demystifies The World Of Clinical Trials
Researchers, patients, and even clinical trials managers are often bewildered by the Byzantine rules and regulations governing clinical trials. Keeping it all straight and up-to-date has, until now, been challenging. This newly released book, edited by Dr Madhu Davies and Dr. Faiz Kermani, demystifies the topic in an exceptionally reader-friendly, yet authoritative format.
Source: www.medicalnewstoday.com

Labels: ,


Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.